Cardiovascular Diseases, Diabetes Mellitus, Dyslipidemias, Hypertension, Myocardial Infarction, Stroke
Conditions
Keywords
cardiovascular diseases, primary prevention, secondary prevention, statins
Brief summary
A cross-sectional real-world data study designed to assess the use of statins in individuals assisted within the primary care system in Brazil.
Detailed description
Considering the high cardiovascular risk associated to high cholesterol levels, assessing the use of statins in secondary prevention as well as primary prevention individuals in real world settings is key to enable public health policy improvements. The aim of the present study is to assess statins use in primary and secondary prevention individuals assisted by community care workers in the primary care system in Brazil, using a free real world data collection tool (epHealth database). Evaluating factors associated with statins use as well as high dose statins use are also objectives of the study.
Interventions
DRUGStatin
Statin use
Sponsors
epHealth
Novartis
Hospital Israelita Albert Einstein
Study design
Observational model
OTHER
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* All individuals aged 18 years or older registered on the epHealth database
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Statin use on secondary prevention | Baseline | Proportion of patients with previous myocardial infarction and/or stroke on statin use |
| Statin use on primary prevention | Baseline | Proportion of patients with hypertension, diabetes and/or dyslipidemia on statin use |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| High dose statin use on secondary prevention | Baseline | Proportion of patients with previous myocardial infarction and/or stroke on high dose statin use |
| High dose statin use on patients with previous myocardial infarction | Baseline | Proportion of patients with previous myocardial infarction on high dose statin |
| High dose statin use on patients with stroke | Baseline | Proportion of patients with previous stroke on high dose statin |
| Statin use on patients with diabetes | Baseline | Proportion of patients with diabetes on statin use |
| Statin use on patients with hypertension | Baseline | Proportion of patients with hypertension on statin use |
| Statin use on patients with previous myocardial infarction | Baseline | Proportion of patients with previous myocardial infarction on statin use |
| High dose statin use on patients with diabetes | Baseline | Proportion of patients with diabetes on high dose statin |
| High dose statin use on patients with hypertension | Baseline | Proportion of patients with hypertension on high dose statin |
| High dose statin use on patients with dyslipidemia | Baseline | Proportion of patients with dyslipidemia on high dose statin |
| Statin use on patients with unknown diagnosis | Baseline | Proportion of patients without previous myocardial infarction and/or stroke or a diagnosis of hypertension, diabetes and/or dyslipidemia on statin use |
| High dose statin use on patients with unknown diagnosis | Baseline | Proportion of patients without previous myocardial infarction and/or stroke or a diagnosis of hypertension, diabetes and/or dyslipidemia on high dose statin use |
| Statin use on patients with dyslipidemia | Baseline | Proportion of patients with dyslipidemia on statin use |
| Statin use on patients with previous stroke | Baseline | Proportion of patients with previous stroke on statin use |
Countries
Brazil
Outcome results
None listed